ABSORB III Randomized Controlled Trial (RCT) (ABSORB-III)
ClinicalTrials.gov NTC01751906
Research payments
$937,956
Through program year 2020, $937,956 in research payments was reported against ABSORB III Randomized Controlled Trial (RCT) (ABSORB-III), across 329 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- NTC01751906
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $937,956 | 329 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- David Metzger Kingsport, TN Named on 10 payments
- Bryan Wilson Charlotte, NC Named on 7 payments
- James Maddux Missoula, MT Named on 6 payments
- Robert Attaran Branford, CT Named on 5 payments
- Jacob Mishell San Francisco, CA Named on 5 payments
- Daniel Spoon Missoula, MT Named on 5 payments
- Jeffrey Moses New York, NY Named on 5 payments
- Ron Waksman Washington, DC Named on 4 payments
- Tomasz Stys Sioux Falls, SD Named on 4 payments
- Aaron Kaplan Lebanon, NH Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.